Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release
- 27 March 2006
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 535 (1-3) , 135-144
- https://doi.org/10.1016/j.ejphar.2006.01.051
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- SSR181507, A Dopamine D2 Receptor Antagonist and 5-HT1A Receptor Agonist. I: Neurochemical and Electrophysiological ProfileNeuropsychopharmacology, 2003
- SSR181507, A Dopamine D2 Receptor Antagonist and 5-HT1A Receptor Agonist. II: Behavioral Profile Predictive of an Atypical Antipsychotic ActivityNeuropsychopharmacology, 2003
- Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 ReceptorsThe Journal of Pharmacology and Experimental Therapeutics, 2002
- DU 127090: a highly potent, atypical dopamine receptor ligand — pilot study of dopamine D2 receptor occupancy after multiple oral administration of DU 127090 to healthy male volunteers, using 11C-raclopride by means of positron emission tomographyEuropean Neuropsychopharmacology, 2000
- D-2 dopamine autoreceptor selective drugs: Do they really exist?Life Sciences, 1990
- Changes in Anterior Pituitary Hormone Levels after Serotonin 1A Receptor stimulationEndocrinology, 1990
- Dopamine: A Prolactin-Inhibiting Hormone*Endocrine Reviews, 1985
- Dopamine-receptor agonists: Mechanisms underlying autoreceptor selectivityJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1985
- On the presence of autoreceptors on dopamine neurons in different brain regionsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1983
- Comparison of dopamine synthesis regulation in the terminals of nigrostriatal, mesolimbic, tuberoinfundibular and tuberohypophyseal neuronsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1979